Ana Priscila Monteiro da Silva

Dr. Ana Priscila Monteiro da Silva


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2024 in Foods
Verified
Journal Article
Open access
PDF file
ASAna Priscila Monteiro da Silva
Ana Priscila Monteiro da Silva
GSGisele Silvestre da Silva
Gisele Silvestre da Silva
FFrancisco Oiram Filho
Francisco Oiram Filho
Maria Francilene Souza SilvaMaria Francilene Souza Silva
Maria Francilene Souza Silva
GZGuilherme Julião Zocolo
Guilherme Julião Zocolo
Edy BritoEdy Brito
Edy Brito
The growing focus on sustainable use of natural resources has brought attention to cashew nut shell liquid (CNSL), a by-product rich in anacardic acids (AAs) with potential applications in diabetes treatment. In this study, three different AAs from CNSL, monoene (15:1, AAn1), diene (15:2, AAn2), and triene (15:3, AAn3), and a mixture of the three (mix) were evaluated as α-glucosidase inhibitors. The samples were characterized by combining 1D and 2D NMR spectroscopy, along with ESI-MS. In vitro assays revealed that AAn1 had the strongest inhibitory effect (IC50 = 1.78 ± 0.08 μg mL−1), followed by AAn2 (1.99 ± 0.76 μg mL−1), AAn3 (3.31 ± 0.03 μg mL−1), and the mixture (3.72 ± 2.11 μg mL−1). All AAs significantly outperformed acarbose (IC50 = 169.3 μg mL−1). In silico docking suggested that polar groups on the aromatic ring are key for enzyme–ligand binding. The double bond at C15, while not essential, enhanced the inhibitory effects. Toxicity predictions classified AAs as category IV, and pharmacokinetic analysis suggested moderately favorable drug-like properties. These findings highlight AAs as a promising option in the search for new hypoglycemic compounds.